Registry of Multicenter Brain-Heart Comorbidity in China
Launched by BEIJING TIANTAN HOSPITAL · Jul 23, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Registry of Multicenter Brain-Heart Comorbidity in China, is studying the connection between brain and heart diseases. Researchers are creating a large database to gather information about patients who have recently been diagnosed with various heart and brain conditions, such as heart attacks, strokes, and heart failure. The goal is to better understand how these diseases affect each other and to improve treatment options for patients.
To participate in this study, you must be at least 18 years old and have been diagnosed with one of the specific cardiovascular conditions identified by the study. Participants will help contribute to a comprehensive database that tracks their health information over time. This study is important because it aims to use advanced technology, including artificial intelligence, to analyze the collected data, ultimately leading to better care for patients with both heart and brain issues. If you are interested in joining, your participation will help researchers gain valuable insights into these serious health conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age \> 18 years old
- • Any of newly diagnosed cardiovascular-related diseases were identified via ICD-10-CM codes: I21, I22, I24 (Ischaemic heart diseases) \[i.e., ACS\], I46 (cardiac arrest), I48 (Atrial fibrillation/flutter), I50 (Heart failure), I71 (Aortic disease), I60 (subarachnoid hemorrhage), I61 (intracerebral hemorrhage), I63 (Cerebral infarction), I65 (Occlusion and stenosis of precerebral arteries), I66 (Occlusion and stenosis of cerebral arteries), I67.1 (cerebral aneurysm), I67.5 (moyamoya diseases), Q28.2 (Arteriovenous malformation of cerebral vessels).
- Exclusion Criteria:
- • ·refuse to participate in the registry
About Beijing Tiantan Hospital
Beijing Tiantan Hospital, affiliated with Capital Medical University, is a leading medical institution in China renowned for its expertise in neurology, neurosurgery, and various other specialties. As a prominent clinical trial sponsor, the hospital is committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on high-quality clinical trials, Beijing Tiantan Hospital adheres to rigorous ethical standards and regulatory requirements, fostering collaboration with academic institutions and industry partners to facilitate the development of cutting-edge therapies and interventions. Its state-of-the-art facilities and experienced research team enable the hospital to play a pivotal role in the global medical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Harbin, Heilongjiang, China
Fuzhou, Fujian, China
Beijing, Beijing, China
Zhengzhou, Henan, China
Beijing, Beijing, China
Xiamen, Fujian, China
Zhengzhou, , China
Shanghai, Shanghai, China
Kunming, Yunnan, China
Beijing, Beijing, China
Beijing, Beijing, China
Beijing, Beijing, China
Shanxi, Shanxi, China
Beijing, Beijing, China
Shenzhen, Guangdong, China
Patients applied
Trial Officials
Shuo Wang, MD
Study Chair
Beijing Tiantan Hospital
Yong Cao, MD
Study Director
Beijing Tiantan Hospital
Dong Xu, MD
Principal Investigator
Beijing Tiantan Hospital
Zening Jin, MD
Principal Investigator
Beijing Tiantan Hospital
Hao Wang, MD
Principal Investigator
Beijing Tiantan Hospital
Shuai Kang, MD
Principal Investigator
Beijing Tiantan Hospital
Yu Chen, MD
Principal Investigator
Beijing Tiantan Hospital
Qingyuan Liu, MD
Principal Investigator
Beijing Tiantan Hospital
Runting Li, MD
Principal Investigator
Beijing Tiantan Hospital
Heze Han, MD
Principal Investigator
Beijing Tiantan Hospital
Wenxiong Song, MD
Principal Investigator
Beijing Tiantan Hospital
Jionghao Xue, MD
Principal Investigator
Beijing Tiantan Hospital
Minghao Liu, MD
Principal Investigator
Beijing Tiantan Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported